Esther Meijer is an internist-nephrologist with specific interest in Autosomal Dominant Polycystic Kidney Disease (ADPKD). At the University Medical Center Groningen (UMCG), she combines clinical work with research. She sees approximately 250 ADPKD patients per year and is study coordinator of a Dutch national observational cohort of ADPKD patients. Her current research focuses on markers of disease progression, and improving treatment in ADPKD. In 2019, she received an early career grant from the Dutch Kidney Foundation to investigate improvement of treatment with a vasopressin V2 receptor antagonist, by decreasing the adverse events.